Aurora Cannabis Operating Income 2017-2025 | ACB
Aurora Cannabis operating income from 2017 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
Aurora Cannabis Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $4 |
| 2024 | $-34 |
| 2022 | $-183 |
| 2021 | $-221 |
| 2020 | $-366 |
| 2019 | $-237 |
| 2018 | $-83 |
| 2017 | $-8 |
| 2017 | $-20 |
| 2016 | $1 |
|
Aurora Cannabis Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-15 |
| 2025-03-31 | $-22 |
| 2024-12-31 | $26 |
| 2024-09-30 | $-2 |
| 2024-06-30 | $1 |
| 2024-03-31 | $3 |
| 2023-12-31 | $-18 |
| 2023-09-30 | $-8 |
| 2023-06-30 | $-12 |
| 2022-12-31 | $-53 |
| 2022-09-30 | $-41 |
| 2022-03-31 | $40 |
| 2021-12-31 | $-44 |
| 2021-09-30 | $-31 |
| 2021-03-31 | $44 |
| 2020-12-31 | $-36 |
| 2020-09-30 | $-32 |
| 2020-03-31 | $56 |
| 2019-12-31 | $-91 |
| 2019-09-30 | $-59 |
| 2019-03-31 | $49 |
| 2018-12-31 | $-61 |
| 2018-09-30 | $-86 |
| 2018-06-30 | |
| 2018-03-31 | $-24 |
| 2017-12-31 | $-12 |
| 2017-09-30 | $-1 |
| 2017-06-30 | |
| 2017-03-31 | $4 |
| 2016-12-31 | $3 |
| 2016-09-30 | $2 |
| 2016-06-30 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.251B | $0.247B |
| Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.559B | 24.96 |
| EssilorLuxottica (ESLOY) | France | $168.705B | 0.00 |
| Boston Scientific (BSX) | United States | $146.614B | 33.53 |
| Stryker (SYK) | United States | $136.781B | 27.16 |
| Medtronic (MDT) | Ireland | $115.955B | 16.35 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.709B | 0.00 |
| Agilent Technologies (A) | United States | $41.609B | 26.93 |
| ResMed (RMD) | United States | $35.788B | 24.77 |
| GE HealthCare Technologies (GEHC) | United States | $34.442B | 16.47 |
| Koninklijke Philips (PHG) | Netherlands | $27.029B | 17.65 |
| Terumo (TRUMY) | Japan | $24.148B | 28.61 |
| Insulet (PODD) | United States | $22.134B | 74.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.343B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.690B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.227B | 7.45 |
| Bio-Rad Laboratories (BIO) | United States | $8.390B | 30.07 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.891B | 10.52 |
| Envista Holdings (NVST) | United States | $3.313B | 19.01 |
| ICU Medical (ICUI) | United States | $3.144B | 21.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.944B | 13.06 |
| Haemonetics (HAE) | United States | $2.444B | 10.91 |
| Perrigo (PRGO) | Ireland | $2.078B | 5.21 |
| LeMaitre Vascular (LMAT) | United States | $1.953B | 41.88 |
| Curaleaf Holdings (CURLF) | Canada | $1.917B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.858B | 11.95 |
| Phibro Animal Health (PAHC) | United States | $1.668B | 16.66 |
| AtriCure (ATRC) | United States | $1.607B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.437B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.421B | 62.27 |
| AdaptHealth (AHCO) | United States | $1.399B | 20.27 |
| Kestra Medical Technologies (KMTS) | United States | $1.363B | 0.00 |
| Neogen (NEOG) | United States | $1.349B | 25.88 |
| BioLife Solutions (BLFS) | United States | $1.321B | 2757.00 |
| InMode (INMD) | Israel | $0.918B | 10.38 |
| Valneva SE (VALN) | France | $0.774B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.492B | 16.94 |
| SNDL (SNDL) | Canada | $0.486B | 0.00 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Evolus (EOLS) | United States | $0.441B | 0.00 |
| CeriBell (CBLL) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.384B | 0.00 |
| Brainsway (BWAY) | Israel | $0.307B | 62.19 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.278B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.273B | 0.00 |
| High Tide (HITI) | Canada | $0.263B | 0.00 |
| Owens & Minor (OMI) | United States | $0.259B | 2.60 |
| Viemed Healthcare (VMD) | United States | $0.249B | 19.49 |
| Sanara MedTech (SMTI) | United States | $0.246B | 0.00 |
| Quanterix (QTRX) | United States | $0.240B | 0.00 |
| Exagen (XGN) | United States | $0.234B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.222B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.210B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 16.38 |
| FitLife Brands (FTLF) | United States | $0.184B | 22.66 |
| Biote (BTMD) | United States | $0.145B | 5.86 |
| Sharps Technology (STSS) | United States | $0.119B | 0.00 |
| Apyx Medical (APYX) | United States | $0.119B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.99 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.061B | 0.00 | |
| Nephros (NEPH) | United States | $0.060B | 47.42 |
| ImmuCell (ICCC) | United States | $0.057B | 33.16 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.036B | 0.00 |
| Zynex (ZYXI) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.032B | 12.50 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |